Reading, MA, United States of America

Denise M O'Hara

This inventor holds 13 USPTO granted patents and 2 published patent applications. Top assignees: Genetics Institute, Inc., Wyeth, Philogen S.p.a.. Active years: 2004-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denise M O'Hara. Retrieved from https://idiyas.com/inventor/denise-m-o-hara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 46.2

Average Co-Inventor Count = 9.1

ph-index = 7

Forward Citations = 373(Granted Patents)


Company Filing History:


Years Active: 2004-2017

Loading Chart...
13 patents (USPTO):Explore Patents

Title: Denise M O'Hara: Pioneering Innovator in Medical Biotechnology

Introduction:

Denise M O'Hara, hailing from Reading, MA, is a remarkable inventor and scientist in the field of medical biotechnology. With an impressive portfolio of 13 granted patents, O'Hara has made significant contributions to the development of novel therapies for inflammatory bowel disease (IBD) and degenerative disorders. In this article, we explore O'Hara's latest patents, career highlights, notable collaborations, and commendable achievements.

Latest Patents:

O'Hara's latest patents demonstrate her innovative approaches to addressing the challenges of IBD treatment and combating degenerative disorders. One remarkable invention is the development of anti-ED-A immunoconjugates for IBD, which utilize specific binding members capable of targeting the ED-A isoform of fibronectin. These immunoconjugates have potential applications in diagnosis, treatment, detection, and imaging of IBD, as well as targeted delivery of therapeutic molecules to IBD tissues.

Another significant patent by O'Hara involves the use of antibodies, including antibody fragments, to inhibit growth and differentiation factor-8 (GDF-8). The patent outlines the application of these antibodies in diagnosing, preventing, and treating degenerative disorders related to muscle, bone, and insulin metabolism. Such breakthrough innovations have the potential to revolutionize the treatment options for individuals suffering from these conditions.

Career Highlights:

Denise M O'Hara's passion for medical biotechnology and dedication to scientific advancements are reflected in her noteworthy career. Having worked at reputable companies such as Genetics Institute, Inc. and Wyeth, she has consistently demonstrated her expertise in the field.

Throughout her career, O'Hara has been involved in various roles, ranging from research and development to project management. Her exemplary work has garnered recognition within the industry and established her as a prominent figure in medical biotechnology.

Collaborations:

Collaborations play a crucial role in fostering innovation, and Denise M O'Hara has had the opportunity to work with esteemed colleagues in her field. Notable coworkers include Geertruida Machteld Veldman and Beatriz M Carreno, who have contributed to their shared research endeavors. Together, their collaboration has resulted in groundbreaking inventions and publications that have substantially advanced the understanding and treatment of medical conditions.

Conclusion:

Denise M O'Hara's impressive portfolio of patents and career highlights underscore her remarkable contributions to the field of medical biotechnology. Through her groundbreaking inventions and collaborations, she has made significant strides in improving the diagnosis and treatment of inflammatory bowel disease and degenerative disorders. O'Hara's dedication to innovation serves as an inspiration to aspiring inventors and researchers in the pursuit of advancements that positively impact healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…